# Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions

> **NCT02432066** · PHASE2 · WITHDRAWN · sponsor: **University of Florida**

## Conditions studied

- Tobacco Use Disorder

## Interventions

- **DRUG:** GTS-21
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02432066
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-09-29
- **Primary completion:** 2018-12-29
- **Final completion:** 2020-12-29
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was not started and participants were not enrolled
- **Last updated:** 2019-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02432066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02432066, "Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02432066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*